Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations.

@article{PeyrinBiroulet2017PatientPO,
  title={Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations.},
  author={Laurent Peyrin-Biroulet and Sanna L{\"o}nnfors and Xavier Roblin and Silvio Danese and Luisa Avedano},
  journal={Journal of Crohn's & colitis},
  year={2017},
  volume={11 1},
  pages={128-133}
}
BACKGROUND AND AIM The aim of this survey was to find out the patients' perspectives concerning biosimilars. METHODS An online survey consisting of 14 questions was made available between November 2014 and October 2015. Only respondents who had heard of biosimilars were asked to respond the final twelve questions. RESULTS A total of 1181 patients responded. Of these, 38% had heard of biosimilars. The respondents worried about biosimilars' safety profile [47.0%], efficacy [40.3%], and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 13 times over the past 90 days. VIEW TWEETS